KRAS and HRAS mutations confer resistance to MET targeting...

Molecular Oncology 2015 / 08 Vol. 9; Iss. 7

KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells

Leiser, Dominic, Medová, Michaela, Mikami, Kei, Nisa, Lluís, Stroka, Deborah, Blaukat, Andree, Bladt, Friedhelm, Aebersold, Daniel M., Zimmer, Yitzhak
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Language:
english
Journal:
Molecular Oncology
DOI:
10.1016/j.molonc.2015.04.001
Date:
August, 2015
File:
PDF, 3.19 MB
english, 2015
Conversion to is in progress
Conversion to is failed